Sign In
Buy AMRN
$14.53
+0.0600 (+0.415%)
At Close: Jun 03, 2026
-- Peer-Reviewed Paper Indicates Icosapent Ethyl (IPE) Reduced Composite Cardiovascular Endpoint Events Regardless of Baseline LDL-C Levels; Significantly Reduced Events by 34% Among Patients with Ver
Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025
08:30am, Wednesday, 19'th Feb 2025
DUBLIN and BRIDGEWATER, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members o
Amarin Receives National Reimbursement for VAZKEPA® in Italy
07:00am, Monday, 16'th Dec 2024
-- Italian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Cardiovascular Risk in Eligible High-Risk Patients 1 -- -- Italy is the Third EU5 Market to Grant
Amarin Appoints Peter Fishman Chief Financial Officer
09:00am, Friday, 13'th Dec 2024
Fishman Previously Served as Global Controller and Principal Financial & Accounting Officer for the Company Fishman Previously Served as Global Controller and Principal Financial & Accounting Officer
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
10:35am, Tuesday, 19'th Nov 2024
Amarin (AMRN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates co
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
10:36am, Thursday, 31'st Oct 2024
AMRN's third-quarter 2024 earnings meet estimates while revenues miss the same. Vascepa's sales in the United States decline year over year.
Amarin Corporation plc (AMRN) Q3 2024 Earnings Call Transcript
08:50pm, Wednesday, 30'th Oct 2024
Amarin Corporation plc (NASDAQ:AMRN ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Mark Marmur - Vice President of Corporate Communications and Investor Relations
DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new supported and/or funded research on the clinical impact of VASCE
DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT® ca
Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat
02:00pm, Thursday, 01'st Aug 2024
Amarin's (AMRN) second-quarter 2024 earnings and revenues beat estimates. Vascepa's sales in the United States decline year over year.
Amarin Corporation plc (AMRN) Q2 2024 Earnings Call Transcript
12:28pm, Wednesday, 31'st Jul 2024
Amarin Corporation plc (NASDAQ:AMRN ) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ET Company Participants Mark Marmur – Vice President, Corporate Communications and Investor Relations Aar
Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update
07:00am, Wednesday, 31'st Jul 2024
-- Cash Position of $307 Million Provides Stable and Strong Capital Foundation – -- Total Net Revenue of $68 Million ($124 Million Year-To-Date) Reflecting Continuing Efforts to Maximize VASCEPA/VAZ
3 Breakthrough Stocks Under $10 Set for Massive Upside
02:26pm, Monday, 29'th Jul 2024
Uncovering affordable breakthrough stocks under $10 in the portfolio can lead to high-price return opportunities. Here, the focus is on three such stocks, each demonstrating strong fundamentals that s
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal
04:15pm, Wednesday, 17'th Jul 2024
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (C
Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024
08:00am, Wednesday, 17'th Jul 2024
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members o
